Literature DB >> 19476742

Essiac: systematic review by the natural standard research collaboration.

Catherine Ulbricht1, Wendy Weissner, Sadaf Hashmi, Tracee Rae Abrams, Cynthia Dacey, Nicole Giese, Paul Hammerness, Dana A Hackman, Jenny Kim, Audrey Nealon, Ruslan Voloshin.   

Abstract

The objective of this study was to evaluate the scientific evidence on the safety and efficacy of Essiac. This review serves as a clinical support tool. Electronic searches were conducted in 10 databases, 20 additional journals (not indexed in common databases), and bibliographies from 50 selected secondary references. No restrictions were placed on the language or quality of the publications. Standardized inclusion and exclusion criteria were used for selection. A review of the literature on Essiac and essiac formulations showed a lack of high-quality clinical trials to substantiate any of Essiac's traditional uses. Weak evidence from preclinical, animal, and laboratory data warranted a discussion regarding Essiac's use for cancer, but the results are inconclusive. Several other essiac preparations are noted in the literature, adding confusion to the exact formula and its proposed benefits. In general, there is a lack of both safety and efficacy data for Essiac and essiac formulations. Well-designed trials testing Essiac or individual herbal components are necessary to make firm recommendations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19476742

Source DB:  PubMed          Journal:  J Soc Integr Oncol        ISSN: 1715-894X


  5 in total

1.  Maturation of the adrenal medulla--IV. Effects of morphine.

Authors:  T R Anderson; T A Slotkin
Journal:  Biochem Pharmacol       Date:  1975-08-15       Impact factor: 5.858

Review 2.  Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews.

Authors:  Paul Posadzki; Leala Watson; Edzard Ernst
Journal:  Eur J Clin Pharmacol       Date:  2012-07-29       Impact factor: 2.953

3.  Spontaneous regression in advanced non-small cell lung cancer.

Authors:  Adam Gladwish; Katy Clarke; Andrea Bezjak
Journal:  BMJ Case Rep       Date:  2010-12-29

Review 4.  The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors.

Authors:  Roy E Strowd; Stuart A Grossman
Journal:  Curr Treat Options Oncol       Date:  2015-08

Review 5.  Biologically-Based Complementary and Alternative Medicine (CAM) Use in Cancer Patients: The Good, the Bad, the Misunderstood.

Authors:  Kathryn Knecht; David Kinder; Amy Stockert
Journal:  Front Nutr       Date:  2020-01-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.